Extended Abstract Submission Deadline Announced for the 16th Emirates Pathology, Digital Pathology & Cancer Conference 2026
The 16th Emirates Pathology, Digital Pathology and Cancer Conference is set to take place from April 09–11, 2026 in Dubai, UAE, with the option to participate virtually, offering global accessibility for researchers, clinicians, oncologists, laboratory experts, and students. In response to the overwhelming interest from the international medical and scientific community, the organizing committee has extended the abstract submission deadline to December 15, 2025, giving authors additional time to prepare and submit their research contributions.
The conference is CME/CPD accredited, providing valuable educational credits for participants looking to advance professional development and stay at the forefront of current medical and technological advancements.
A Premier Global Platform for Pathology and Cancer Research
Pathology continues to play a critical role in medical diagnostics, personalized medicine, and cancer management. With rapid advancements in digital pathology, artificial intelligence, molecular diagnostics, and precision oncology, the demand for collaborative knowledge exchange has never been more essential. The 16th Emirates Pathology, Digital Pathology and Cancer Conference serves as a dynamic international stage where research meets innovation, theory meets practice, and professionals connect to inspire real-world transformation.
Over three days, the conference will bring together leading pathologists, oncologists, radiologists, cytologists, laboratory medicine specialists, biomedical engineers, pharmaceutical professionals, and clinical researchers from across the world to share findings, discuss challenges, and explore future trends in diagnostics and therapeutic sciences.
Why Present Your Research at This Global Event?
Presenting an abstract at this conference provides numerous professional and academic advantages, especially for early-career researchers, clinicians engaged in scientific work, and experts striving to influence global medical practices. Key benefits include:
• Showcase research to an international audience
Gain visibility and recognition by presenting breakthroughs and innovative approaches before global experts in pathology and oncology. This exposure amplifies academic credibility and opens doors for collaborative research.
• Receive professional evaluation and constructive feedback
Experienced session chairs and panel experts provide valuable insights that can strengthen research quality, enhance publication readiness, and guide future investigation.
• Earn CME/CPD credits
All presenters receive internationally recognized CME/CPD certification, adding value to academic portfolios and helping healthcare professionals stay compliant with continuing education requirements.
• Build global connections
Network with top institutions, leading medical innovators, publishers, industry representatives, and research funding partners. Many past delegates have formed research collaborations, co-authorships, and academic partnerships through conference networking.
Research Themes & Submission Categories
The conference welcomes abstracts in all major areas of pathology and cancer research, including but not limited to:
Digital Pathology & Artificial Intelligence in Diagnostics
Cancer Biology & Oncology Research
Histopathology & Cytopathology
Molecular & Genetic Diagnostics
Laboratory Medicine & Biomarkers
Hematopathology & Immunopathology
Precision Medicine & Personalized Therapeutics
Tumor Pathology & Clinical Oncology Case Studies
Biobanking and Biospecimen Research
Diagnostic Imaging and Clinical Correlation
Researchers may submit abstracts for oral presentation, poster presentation, or virtual presentation, and accepted authors will receive official presentation confirmation shortly after review.
Hybrid Participation for Global Accessibility
The conference is hybrid—participants can attend in person in Dubai or join virtually from anywhere in the world. Virtual attendees enjoy access to live sessions, e-posters, recordings, digital certification, and interactive Q&A panels.
For many professionals balancing clinical responsibilities and academic commitments, the virtual option offers flexibility without compromising the quality of participation.
Why Dubai? A Center for Global Medical Innovation
Dubai continues to emerge as a world-class hub for medical education, healthcare innovation, and scientific exchange. With modern conference facilities, excellent connectivity, and an international community of professionals, it provides an inspiring environment to advance global medical progress.
How to Submit Your Abstract
Researchers and professionals are encouraged to submit their abstracts before the extended deadline:
Submit Your Abstract:
https://pathology.utilitarianconferences.com/submit-abstract
For Assistance or Queries:
Contact via WhatsApp: https://wa.me/+971551792927
Final Call to the Scientific Community
The abstract deadline extension to December 15, 2025, offers a valuable opportunity for authors to refine their research and join a global movement dedicated to improving diagnostics, treatment, and outcomes in pathology and cancer care.
Whether you are an experienced researcher or an emerging scientist, this conference provides a platform to share knowledge, exchange ideas, and contribute to advancements that can reshape the future of healthcare.
Take the Next Step in Your Scientific Journey
Prepare your abstract, inspire global audiences, and take your research to the next level. Submit your work today and become part of the 16th Emirates Pathology, Digital Pathology & Cancer Conference 2026.
.png)
Comments
Post a Comment